Aoki Diabetes Research Institute
|
|
Aoki Diabetes Research Institute
|
| About ADRI |
|
|
MAT®
Treatment
This session uses a complex proprietary methodology under the direction of a physician in a healthcare setting. Patients spend most of the time in big lounge chairs, reading, watching TV, doing homework from school or business, but are able to walk around as needed. The remainder of the week the patient follows American Diabetes Association (ADA) or American Association of Clinical Endocrinologists (AACE) recommended therapy. The patient and physician work in partnership to optimize health with attention to diet, exercise, and treatment of other medical problems such as hypertension. MAT® treatment, metabolic activation therapy, has had many names over the past 20 years such as: hepatic activation, chronic intermittent intravenous insulin therapy (CIIIT), pulsatile intravenous insulin therapy (PIVIT). Patients and physicians should be very wary of companies or persons who claim to offer this therapy, but offer it under names other than metabolic activation therapy. Copyright 2010 Aoki Diabetes Research Institute. ALL RIGHTS RESERVED |